Abstract

Background & aims: We created and validated a clinical decision support tool (CDST) to predict outcomes of vedolizumab therapy for ulcerative colitis (UC).

Tags

Antibodies, Biologic, Drug Therapy, Gastrointestinal Agents, Monoclonal, Personalized Medicine, Prognostic Factor, Response to Treatment, therapeutic use, Treatment Outcome, Ulcerative Colitis

Read More